Download PDF
Int Arch Otorhinolaryngol 2015; 19(01): 086-089
DOI: 10.1055/s-0034-1378138
Update Article
Thieme Publicações Ltda Rio de Janeiro, Brazil

Therapeutic Options in Idiopathic Burning Mouth Syndrome: Literature Review

Ivan Miziara
1   Department of Otolaryngology, Universidade de São Paulo, São Paulo, Brazil
,
Azis Chagury
1   Department of Otolaryngology, Universidade de São Paulo, São Paulo, Brazil
,
Camila Vargas
1   Department of Otolaryngology, Universidade de São Paulo, São Paulo, Brazil
,
Ludmila Freitas
1   Department of Otolaryngology, Universidade de São Paulo, São Paulo, Brazil
,
Ali Mahmoud
1   Department of Otolaryngology, Universidade de São Paulo, São Paulo, Brazil
› Author Affiliations
Further Information

Publication History

06 March 2014

15 April 2014

Publication Date:
09 July 2014 (online)

Also available at
   Permissions and Reprints

Abstract

Introduction Burning mouth syndrome (BMS) is characterized by a burning sensation in the tongue, palate, lips, or gums of no well-defined etiology. The diagnosis and treatment for primary BMS are controversial. No specific laboratory tests or diagnostic criteria are well established, and the diagnosis is made by excluding all other possible disorders.

Objective To review the literature on the main treatment options in idiopathic BMS and compare the best results of the main studies in 15 years.

Data Synthesis We conducted a literature review on PubMed/MEDLINE, SciELO, and Cochrane-BIREME of work in the past 15 years, and only selected studies comparing different therapeutic options in idiopathic BMS, with preference for randomized and double-blind controlled studies.

Final Comments Topical clonazepam showed good short-term results for the relief of pain, although this was not presented as a definitive cure. Similarly, α-lipoic acid showed good results, but there are few randomized controlled studies that showed the long-term results and complete remission of symptoms. On the other hand, cognitive therapy is reported as a good and lasting therapeutic option with the advantage of not having side effects, and it can be combined with pharmacologic therapy.

Keywords

treatment - stomatodynia - burning mouth syndrome
 

  • References

  • 1 Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. Am Fam Physician 2002; 65 (4) 615-620
    Google Scholar
  • 2 Merskey H, Bugduk N. Task on Taxonomy. Seattle: Classification of Chronic Pain. Description of Chronic Pain Syndromes and Definition of Pain Terms. Seattle, WA: IASP Press; 1994
    Google Scholar
  • 3 Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003; 14 (4) 275-291
    CrossrefPubMedGoogle Scholar
  • 4 Muzyka BC, De Rossi SS. A review of burning mouth syndrome. Cutis 1999; 64 (1) 29-35
    Google Scholar
  • 5 Minguez-Sanz MP, Salort-Llorca C, Silvestre-Donat FJ. Etiology of burning mouth syndrome: a review and update. Med Oral Patol Oral Cir Bucal 2011; 16 (2) e144-e148
    Google Scholar
  • 6 Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005; 25 (1) CD002779
    Google Scholar
  • 7 Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999; 28 (8) 350-354
    Google Scholar
  • 8 Ito M, Kurita K, Ito T, Arao M. Pain threshold and pain recovery after experimental stimulation in patients with burning mouth syndrome. Psychiatry Clin Neurosci 2002; 56 (2) 161-168
    CrossrefGoogle Scholar
  • 9 Albuquerque RJ, de Leeuw R, Carlson CR, Okeson JP, Miller CS, Andersen AH. Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain 2006; 122 (3) 223-234
    CrossrefGoogle Scholar
  • 10 Sardella A, Lodi G, Demarosi F, Tarozzi M, Canegallo L, Carrassi A. Hypericum perforatum extract in burning mouth syndrome: a randomized placebo-controlled study. J Oral Pathol Med 2008; 37 (7) 395-401
    CrossrefGoogle Scholar
  • 11 López-Jornet P, Camacho-Alonso F, Andujar-Mateos P. A prospective, randomized study on the efficacy of tongue protector in patients with burning mouth syndrome. Oral Dis 2011; 17 (3) 277-282
    CrossrefGoogle Scholar
  • 12 Petruzzi M, Lauritano D, De Benedittis M, Baldoni M, Serpico R. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study. J Oral Pathol Med 2004; 33 (2) 111-114
    CrossrefGoogle Scholar
  • 13 Marino R, Torretta S, Capaccio P, Pignataro L, Spadari F. Different therapeutic strategies for burning mouth syndrome: preliminary data. J Oral Pathol Med 2010; 39 (8) 611-616
    CrossrefGoogle Scholar
  • 14 Silvestre FJ, Silvestre-Rangil J, Tamarit-Santafé C, Bautista D. Application of a capsaicin rinse in the treatment of burning mouth syndrome. Med Oral Patol Oral Cir Bucal 2012; 17 (1) e1-e4
    Google Scholar
  • 15 Gremeau-Richard C, Woda A, Navez ML , et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 2004; 108 (1–2) 51-57
    CrossrefGoogle Scholar
  • 16 Rodríguez de Rivera Campillo E, López-López J, Chimenos-Küstner E ; Rodríguez de RCE. Response to topical clonazepam in patients with burning mouth syndrome: a clinical study. Bull Group Int Rech Sci Stomatol Odontol 2010; 49 (1) 19-29
    Google Scholar
  • 17 Amos K, Yeoh SC, Farah CS. Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study. J Orofac Pain 2011; 25 (2) 125-130
    Google Scholar
  • 18 Heckmann SM, Kirchner E, Grushka M, Wichmann MG, Hummel T. A double-blind study on clonazepam in patients with burning mouth syndrome. Laryngoscope 2012; 122 (4) 813-816
    CrossrefGoogle Scholar
  • 19 Ko JY, Kim MJ, Lee SG, Kho HS. Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS). Arch Gerontol Geriatr 2012; 55 (3) 755-761
    CrossrefGoogle Scholar
  • 20 Bergdahl J, Anneroth G, Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med 1995; 24 (5) 213-215
    CrossrefGoogle Scholar
  • 21 Femiano F, Gombos F, Scully C. Burning Mouth Syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy. Med Oral 2004; 9 (1) 8-13
    Google Scholar
  • 22 Komiyama O, Nishimura H, Makiyama Y , et al. Group cognitive-behavioral intervention for patients with burning mouth syndrome. J Oral Sci 2013; 55 (1) 17-22
    CrossrefGoogle Scholar
  • 23 Kaptchuk TJ. Acupuncture: theory, efficacy, and practice. Ann Intern Med 2002; 136 (5) 374-383
    CrossrefGoogle Scholar
  • 24 Yan Z, Ding N, Hua H. A systematic review of acupuncture or acupoint injection for management of burning mouth syndrome. Quintessence Int 2012; 43 (8) 695-701
    Google Scholar
  • 25 López-Jornet P, Camacho-Alonso F, Molino-Pagan D. Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome. J Oral Pathol Med 2013; 42 (4) 295-301
    CrossrefGoogle Scholar
  • 26 Spanemberg JC, Cherubini K, de Figueiredo MA, Gomes AP, Campos MM, Salum FG. Effect of an herbal compound for treatment of burning mouth syndrome: randomized, controlled, double-blind clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 113 (3) 373-377
    CrossrefGoogle Scholar
  • 27 Femiano F, Gombos F, Scully C, Busciolano M, De Luca P. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 2000; 6 (5) 274-277
    Google Scholar
  • 28 Femiano F, Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 2002; 31 (5) 267-269
    CrossrefGoogle Scholar
  • 29 López-D'alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal 2011; 16 (5) e635-e640
    Google Scholar
  • 30 Cavalcanti DR, da Silveira FR. Alpha lipoic acid in burning mouth syndrome—a randomized double-blind placebo-controlled trial. J Oral Pathol Med 2009; 38 (3) 254-261
    CrossrefGoogle Scholar
  • 31 Carbone M, Pentenero M, Carrozzo M, Ippolito A, Gandolfo S. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain 2009; 13 (5) 492-496
    CrossrefGoogle Scholar
  • 32 López-Jornet P, Camacho-Alonso F, Leon-Espinosa S. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study. J Oral Rehabil 2009; 36 (1) 52-57
    CrossrefGoogle Scholar
  • 33 Yamazaki Y, Hata H, Kitamori S, Onodera M, Kitagawa Y. An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107 (1) e6-e11
    CrossrefGoogle Scholar